Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03342417
Title Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors ExcellaBio LLC
Indications

stomach cancer

breast cancer

ovarian cancer

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.